Welcome to our eleventh episode of the GHAPP & RhAPP biosimilar podcast series! Our host Amanda Mixon, PA-C, engages in an insightful conversation with Naomi A. Amudala, CRNP, MSN, diving into a crucial topic in biosimilar adoption: The Nocebo Effect.
As biosimilars continue to reshape treatment options in gastroenterology and rheumatology, understanding the nocebo effect—where negative patient expectations contribute to perceived or real adverse effects—becomes essential for advanced practice providers (APPs).
Throughout this episode, Amanda and Naomi explore, the science behind the nocebo effect and how it differs from the placebo effect. Key research findings on the impact of the nocebo effect in biosimilar use. Real-world clinical implications of negative patient perceptions and how they can affect treatment adherence. Practical strategies to counteract the nocebo effect, including effective patient counseling, education, and communication techniques.
This episode is packed with valuable insights for APPs navigating biosimilar adoption and looking to build patient trust and confidence in these treatments.
Tune in to gain a deeper understanding of patient psychology and learn how proactive communication can enhance patient outcomes in biosimilar therapy!
Please take our evaluation regarding this podcast here: https://www.rhapp.org/bio-podcast-eval
